Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

10.1183/09031936.06.00025805

10.1378/chest.128.4.2099

10.1513/pats.200504-026SR

10.1164/rccm.200601-023OC

10.1136/bmj.331.7519.750

de Valliere S, Barker RD. Residual lung damage after completion of treatment for multidrug-resistant tuberculosis.Int J Tuberc Lung Dis2004;8:767–771.

Bateman ED, Feldman C, O'Brien J, Plit M, Joubert JR. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision.S Afr Med J2004;94:559–575.

10.1016/S0140-6736(04)16900-6

10.1164/rccm.200203-245OC

10.1378/chest.121.5_suppl.127S

10.1183/09031936.03.00405703

Tirimanna PR, van Schayck CP, den Otter JJ, van Weel C, van Herwaarden CL, van den Boom G, van Grunsven PM, van den Bosch WJ. Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977?Br J Gen Pract1996;46:277–281.

10.1183/09031936.06.00124605

10.1111/j.1440-1843.2004.00637.x

10.1136/thorax.55.9.789

10.1016/S0140-6736(05)67632-5

Schellevis FG, Van de Lisdonk EH, Van der Velden J, Hoogbergen SH, Van Eijk JT, Van Weel C. Consultation rates and incidence of intercurrent morbidity among patients with chronic disease in general practice.Br J Gen Pract1994;44:259–262.

10.1016/S0140-6736(96)07492-2

10.1183/09031936.06.00024505

10.1378/chest.122.6.1994

10.1016/j.amjmed.2005.06.041

10.1378/chest.128.3.1239

10.1016/S0140-6736(05)66781-5

10.1183/09031936.06.00062305

10.1086/340316

Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta D, Katiyar SK, Kumar R, Shah B, Vijayan VK. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure.Indian J Chest Dis Allied Sci2006;48:23–29.

Al-Fayez SF, Salleh M, Ardawi M. Azahran FM. Effects of sheesha and cigarette smoking on pulmonary function of Saudi males and females.Trop Geogr Med1988;40:115–123.

10.1016/S0140-6736(96)08061-0

10.1186/1476-069X-4-7

10.1164/ajrccm.150.5.7952544

10.1006/enrs.1994.1029

10.1164/ajrccm.152.3.7663813

10.1136/thx.42.4.241

10.1164/rccm.167.5.787

10.1016/S0140-6736(05)66845-6

10.1016/j.annepidem.2004.01.009

10.1183/09031936.06.00000806

10.1183/09031936.06.00052705

10.1016/j.annepidem.2004.12.014

Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000.MMWR Surveill Summ2002;51:1–16.

10.1183/09031936.94.07030477

10.1001/jama.1994.03520190043033

10.1164/ajrccm.162.6.2003112

10.1164/ajrccm/138.4.837

10.1136/bmj.303.6804.671

10.1164/ajrccm.149.3.8118627

10.1034/j.1399-3003.1999.13e28.x

10.1016/0048-9697(92)90469-9

10.1164/ajrccm/147.5.1151

Calverley PMA. Neuropsychological deficits in chronic obstructive pulmonary disease [editorial].Monaldi Arch Chest Dis1996;51:5–6.

10.1378/chest.128.4.2005

10.1378/chest.104.1.254

10.1164/arrd.1986.134.5.930

10.1183/09031936.05.00035205

10.1183/09031936.02.00023202

10.1136/thorax.58.8.654

10.1136/thorax.58.8.659

10.1056/NEJMoa030287

10.5694/j.1326-5377.1990.tb125351.x

10.1136/thx.54.1.1

Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Fox BJ, Goldstein MG, Gritz E, Hasselblad V, Heyman RB, Jaen CR,et al.; The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report.JAMA2000;28:3244–3254.

Glynn TJ, Manley MW, Pechacek TF. Physician-initiated smoking cessation program: the National Cancer Institute trials.Prog Clin Biol Res1990;339:11–25.

10.1136/bmj.321.7257.355

10.1016/S0140-6736(00)04724-3

10.1056/NEJM199903043400903

10.1001/jama.296.1.56

10.1001/archinte.166.15.1561

10.1001/jama.296.1.64

10.1136/bmj.38628.676088.55

10.1016/j.ypmed.2004.01.026

10.1136/tc.2005.014704

10.1164/ajrccm.155.1.9001300

10.1002/j.2048-7940.1991.tb01213.x

Ashikaga T, Vacek PM, Lewis SO. Evaluation of a community-based education program for individuals with chronic obstructive pulmonary disease.J Rehabil1980;46:23–27.

10.1037/0278-6133.9.3.237

10.1164/ajrccm.152.3.7663796

Stewart MA. Effective physician-patient communication and health outcomes: a review.CMAJ1995;152:1423–1433.

10.1097/00001888-199511000-00008

10.1164/ajrccm.155.3.9116986

10.1056/NEJM199906243402503

10.1016/S0140-6736(98)10019-3

10.1136/bmj.320.7245.1297

10.1164/ajrccm/138.4.850

10.1164/ajrccm/139.5.1188

10.1136/bmj.297.6662.1506

Higgins BG, Powell RM, Cooper S, Tattersfield AE. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis.Eur Respir J1991;4:415–420.

10.1378/chest.107.2.401

Guyatt GH, Townsend M, Pugsley SO, Keller JL, Short HD, Taylor DW, Newhouse MT. Bronchodilators in chronic air-flow limitation: effects on airway function, exercise capacity, and quality of life.Am Rev Respir Dis1987;135:1069–1074.

10.1136/thx.2003.019620

10.1183/09031936.04.00116004

10.1183/09031936.02.00238702

10.1378/chest.115.4.957

10.1164/ajrccm.164.5.2007006

10.1183/09031936.03.00083703

10.7326/0003-4819-143-5-200509060-00007

10.1378/chest.127.3.809

10.1378/chest.105.5.1411

10.1378/chest.112.6.1514

10.1159/000029295

Taylor DR, Buick B, Kinney C, Lowry RC, McDevitt DG. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction.Am Rev Respir Dis1985;131:747–751.

10.1034/j.1399-3003.2000.15e11.x

10.1378/chest.119.6.1661

10.1053/rmed.2002.1380

10.1136/thx.42.10.773

10.1016/S0954-6111(06)80031-4

10.1378/chest.91.6.804

10.1056/NEJM200012283432601

10.1164/rccm.2112055

10.1183/09031936.03.00013303

10.1016/S0140-6736(03)12459-2

10.1183/09031936.03.00031402

10.1183/09031936.04.00121404

10.1164/rccm.200206-512OC

10.1136/thx.2005.045385

10.1378/chest.124.3.834

10.1183/09031936.03.00027003

10.1164/ajrccm.153.6.8665061

10.1164/ajrccm.150.1.8025735

10.1164/ajrccm/146.3.800

10.1378/chest.125.6.2011

10.1056/NEJM199409223311206

Wongsurakiat P, Lertakyamanee J, Maranetra KN, Jongriratanakul S, Sangkaew S. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients.J Med Assoc Thai2003;86:497–508.

10.1093/infdis/169.1.68

10.1136/jech.52.2.120

10.1183/09031936.05.00055705

10.1056/NEJMoa022678

Advisory Committee on Immunization Practices. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP) [Internet].MMWR Morb Mortal Wkly Rep1997;46(RR-08):1–24. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/00047135.htm.

10.1136/thx.2005.043323

10.1136/bmj.2.5258.979

10.1136/bmj.1.5169.297

10.1136/bmj.1.5499.1317

10.1136/bmj.4.5678.265

10.1159/000196540

10.1378/chest.92.4.618

10.1378/chest.97.1.75

10.1183/09031936.95.08081398

10.1164/ajrccm/136.1.225

10.1016/S0954-6111(05)80337-3

10.1136/thx.40.11.832

Boman G, Backer U, Larsson S, Melander B, Wahlander L. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.Eur J Respir Dis1983;64:405–415.

Rasmussen JB, Glennow C. Reduction in days of illness after long-term treatment with N- acetylcysteine controlled-release tablets in patients with chronic bronchitis.Eur Respir J1988;1:351–355.

10.1016/S0140-6736(05)66456-2

10.1164/ajrccm.156.6.9612096

Li J, Zheng JP, Yuan JP, Zeng GQ, Zhong NS, Lin CY. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease.Chin Med J (Engl)2004;117:828–834.

10.1164/ajrccm.156.6.ed15-97

10.1378/chest.114.2_Supplement.133S

10.1016/S0140-6736(96)90011-2

10.1136/thx.52.2008.S16

10.1136/thorax.57.11.939

Eiser N, Denman WT, West C, Luce P. Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the “pink puffer” syndrome.Eur Respir J1991;4:926–931.

10.1136/thx.44.5.387

10.1056/NEJM198112313052703

10.1016/0007-0971(87)90163-X

10.1164/ajrccm.157.6.9711061

10.1164/rccm.200508-1211ST

10.1183/09031936.99.13112599

10.1111/j.1445-5994.1999.tb01589.x

10.1016/S0140-6736(99)07042-7

10.1016/S0140-6736(94)90568-1

10.1183/09031936.94.07020269

10.1136/thx.32.3.307

10.7326/0003-4819-93-3-391

Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema.Lancet1981;1:681–686.

10.1056/NEJM199509143331107

10.1378/chest.116.2.521

Mehran RJ, Deslauriers J. Indications for surgery and patient work-up for bullectomy.Chest Surg Clin N Am1995;5:717–734.

10.1016/j.athoracsur.2006.05.069

10.1164/ajrccm.155.3.9117010

10.1056/NEJM199003153221110

Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report—1998.J Heart Lung Transplant1998;17:656–668.

10.1016/S0140-6736(97)06405-2

10.1097/00007890-199810150-00033

10.1056/NEJM199903253401207

10.1016/S0025-7125(05)70368-0

10.1053/stcs.2001.24619

10.1183/09031936.98.11010198

10.1016/S0272-5231(03)00066-2

10.1183/09031936.04.00014304

10.1016/S0002-9343(98)00290-3

Gibson PG, Wlodarczyk JH, Wilson AJ, Sprogis A. Severe exacerbation of chronic obstructive airways disease: health resource use in general practice and hospital.J Qual Clin Pract1998;18:125–133.

10.7326/0003-4819-106-2-196

10.1016/S0140-6736(80)91008-9

10.1183/09031936.05.00024804

10.1378/chest.117.2.398

10.1183/09031936.03.00078002

10.1164/ajrccm.161.5.9908022

10.1136/thorax.58.1.73

10.1164/ajrccm.152.4.7551388

Pela R, Marchesani F, Agostinelli C, Staccioli D, Cecarini L, Bassotti C, Sanguinetti CM. Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation.Monaldi Arch Chest Dis1998;53:262–267.

10.1056/NEJMoa012561

10.1164/rccm.200308-1181OC

10.1378/chest.118.6.1557

10.1136/thorax.58.8.680

10.1164/rccm.200412-1747OC

10.1016/S0196-0644(89)80837-6

10.1378/chest.117.5.1345

10.1111/j.1365-2796.2005.01503.x

10.1161/01.CIR.0000070953.76250.B9

10.1136/bmj.321.7271.1265

10.1136/thorax.57.2.167

10.1136/thorax.55.11.907

10.1183/09031936.03.00015603

10.1164/ajrccm.154.2.8756814

10.1016/S0140-6736(98)11326-0

10.1056/NEJM199906243402502

10.1164/ajrccm.165.5.2109093

10.1056/NEJMoa023161

10.1136/thx.2005.041863

10.1164/ajrccm.154.4.8887592

10.1136/bmj.316.7147.1791

10.1016/S0140-6736(97)11048-0

Soderstrom L, Tousignant P, Kaufman T. The health and cost effects of substituting home care for inpatient acute care: a review of the evidence.CMAJ1999;160:1151–1155.

National Institute for Clinical Excellence (NICE). Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.Thorax2004;59:1–232.

10.1164/ajrccm/145.6.1328

10.1378/chest.115.1.38

Lloberes P, Ramis L, Montserrat JM, Serra J, Campistol J, Picado C, Agusti-Vidal A. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease.Eur Respir J1988;1:536–539.

10.1056/NEJM198408093110601

10.1016/0735-6757(90)90076-C

10.1136/bmj.327.7416.643

10.1136/thx.2004.036046

10.1164/ajrccm.164.9.2105011

10.1136/thorax.57.8.672

10.1136/thorax.57.12.1087

Greenstone M, Lasserson TJ. Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease.Cochrane Database Syst Rev2003;1:CD000223.

10.1136/bmj.326.7382.185

10.7326/0003-4819-120-9-199405010-00008

10.1056/NEJM199509283331301

10.1164/ajrccm.151.6.7767523

10.1016/0140-6736(93)90696-E

10.1016/S0140-6736(00)02323-0

10.1164/ajrccm.161.5.9902018

10.1164/ajrccm.163.1.ats1000

10.1136/thorax.56.9.708

10.1007/s00134-002-1478-0

10.1001/jama.287.3.345

10.1056/NEJM199502093320601

10.1164/ajrccm.150.4.7921460

10.1183/09031936.98.11061349

10.1164/ajrccm.159.1.9803117

10.1001/jama.1991.03470010084035

10.1136/thorax.55.11.902

10.1001/jama.284.22.2877

10.1136/bmj.325.7370.938

Stoller JK, Lange PA. Inpatient management of chronic obstructive pulmonary disease.Respir Care Clin N Am1998;4:425–438.

10.1136/thx.36.8.585

10.1378/chest.116.2.416

10.1136/thorax.58.10.861

10.1183/09031936.03.00075203

10.1111/j.1445-5994.2004.00672.x